UOTTAIMCU
LGND icon

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Ligand Pharmaceuticals LGND Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$171K Buy
+542
New +$128K 0.02% 171

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s LGND Position: Q2 2026 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 542 shares worth $171K. The stake represents 0.02% of the portfolio and ranks #171 among its holdings.

270 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • University of Texas/Texas AM Investment Management Co (UTIMCO) held 542 shares of Ligand Pharmaceuticals worth $171K as of Q2 2026.
  • Ligand Pharmaceuticals was a new University of Texas/Texas AM Investment Management Co (UTIMCO) position in Q2 2026.
  • Ligand Pharmaceuticals made up 0.02% of University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio in Q2 2026, its #171 holding.
  • 270 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q2 2026, filed 3 Aug 2026.